Insider · CIK 0001966861
Richard Newcomb Stillwell
Files at TNXP (Tonix Pharmaceuticals Holding Corp.). First filing Jun 9, 2026, latest Jun 9, 2026.
In brief
Richard Newcomb Stillwell files SEC Form 4 as director at TNXP (Tonix Pharmaceuticals Holding Corp.). Since Jun 9, 2026, Richard Newcomb Stillwell has reported 1 open-market buy worth $58k and 0 open-market sells worth $0, the latest filed on Jun 9, 2026.
A track record needs three past buys with six months of prices behind them; Richard Newcomb Stillwell has 0, so none is measured yet.
The newest scored trade: bought $58k of TNXP on Jun 8, 2026, filed Jun 9, 2026, scored 63 (notable). In the last 12 months: 1 buy worth $58k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNXP: Tonix Pharmaceuticals Holding Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Tonix Pharmaceuticals Holding Corp. | $58k 5,000 shares | - | +6% from low-81% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | POpen-market purchase Common Stock, $0.001 par value | +5,000 | $11.65 | $58k | 5,000 | Jun 9, 2026 |
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +22,700 | $0.00 | $0 | 22,700 | May 14, 2026 |
| May 13, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +10,000 | $0.00 | $0 | 10,000 | May 15, 2025 |
| May 23, 2024 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +104,621 | $0.00 | $0 | 104,621 | May 24, 2024 |
Questions about Richard Newcomb Stillwell
Answered from the filings on this page, as of the latest one.
Is Richard Newcomb Stillwell buying or selling?
In the last 12 months Richard Newcomb Stillwell reported 1 open-market buy worth $58k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $58k of TNXP on Jun 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Richard Newcomb Stillwell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard Newcomb Stillwell has 0.
Where does Richard Newcomb Stillwell file Form 4?
Richard Newcomb Stillwell has filed Form 4 at TNXP (Tonix Pharmaceuticals Holding Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.